Patent details

Basic Information

Publication number:

EP2842575

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP141827329

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Auristatin drug linker conjugates

French Title of Invention:

Conjugués lieurs de médicament auristatin

German Title of Invention:

Auristatin mit einem Heilmittel bindenden Konjugat

SPC Number:

Dates

Filing date:

18/03/2009

Grant date:

27/09/2017

EP Publication Date:

04/03/2015

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

27/09/2017

EP B1 Publication Date:

27/09/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

18/03/2018

Expiration date:

18/03/2029

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

27/09/2017

 

 

Name:

Seattle Genetics, Inc.

Address:

21823 30th Drive, S.E., Bothell, WA 98021, United States (US)

Inventor

1

Name:

Senter, Peter

Address:

United States (US)

2

Name:

Bovee, Timothy

Address:

United States (US)

3

Name:

Doronina, Svetlana

Address:

United States (US)

Priority

1

Priority Number:

37705 P

Priority Date:

18/03/2008

Priority Country:

United States (US)

2

Priority Number:

44431 P

Priority Date:

11/04/2008

Priority Country:

United States (US)

Classification

IPC classification:

A61K 38/00; C07K 5/02; A61K 47/65; A61K 47/68;

Publication

European Patent Bulletin

Issue number:

201739

Publication date:

27/09/2017

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages
31/07/2018	Outgoing Correspondence	1